A purine polymerizable high-refractive monomer and its application
By designing and synthesizing (meth)acrylate high-refractive monomers with purine-containing structures, the high cost and color odor problems of sulfur-containing compounds in existing high-refractive monomers are solved, and the combination of high refractive index and light color characteristics is achieved. , has application potential in the field of optical films.
Patent Information
- Application Number
- CN202311476462.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-11-07
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2043-11-07
AI Technical Summary
Existing high-refractive monomers often use sulfur-containing compounds when increasing the refractive index, which leads to expensive raw materials and color problems and odors, which limits their application. It is important to seek a monomer with high refractive index and improving the properties of the short board.
Design and synthesize (meth)acrylate high refractive monomers containing purine structure fragments. By reacting with (meth)acryloyl chloride acylation, purine polymerizable monomers with high refractive index and light color, and are used in In the optical film.
A high-refractive monomer with a refractive index higher than 1.6 is achieved, which avoids the color and odor problems of high sulfur-containing monomers, and has application potential in the field of high-refractive optical devices.
Smart Images

Figure QLYQS_1 
Figure QLYQS_2 
Figure QLYQS_3
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of organic chemistry, and in particular to a purine polymerizable high-refractive monomer and application thereof. Background Art
[0002] Currently, in the synthesis process of various latest polymerizable high-refractive monomers, many monomers with a refractive index exceeding 1.6 are achieved by increasing the sulfur content in the molecular structure. This method can effectively increase the refractive index of the monomer, but sulfur-containing compounds also have some disadvantages, such as the relatively expensive raw material price itself, and when the sulfur element increases to a certain level, many will show a certain color. In addition, the odor problem of sulfur-containing compounds will also limit the application of these monomers. Therefore, it is particularly important to find a high refractive index and other types of high-refractive monomers that can greatly improve some of the shortcomings of the current monomers. Studies have found that purine compounds, as a natural product, are compounds with a high refractive index. Therefore, it is very meaningful to introduce purine compounds into polymerizable (meth) acrylate groups through structural design, and design and synthesize some polymerizable monomers with a high refractive index. Summary of the invention
[0003] The technical problem to be solved by the present invention is to design and synthesize a class of (meth) acrylate high-refractive monomers containing purine structural fragments, which have the effects of being polymerizable and having a high refractive index.
[0004] In order to solve the above problems, the technical solution provided by the present invention is as follows:
[0005] A purine polymerizable high refractive monomer, the structural formula of which is as follows:
[0006]
[0007] Wherein R1 is a methyl group or a hydrogen atom, R2 is a hydrogen atom, a methylthio group or a phenylthio group, and X is O, NH, or S.
[0008] Preferably, the monomer has the following structural formula:
[0009]
[0010] R is selected from hydrogen or methyl.
[0011] Preferably, the monomer is specifically:
[0012]
[0013] Preferably, a high refractive monomer containing a purine structure comprises the monomer described above, and its use in an optical film.
[0014] Preferably, the monomers described above are used in optical films.
[0015] If there is a conflict between the Chinese name and the structural formula of the compound in the present invention, the structural formula shall prevail, unless there is an obvious error in the structural formula.
[0016] The beneficial effect of the present invention is that the present invention obtains purine polymerizable (meth) acrylate high refractive monomers by introducing purine compounds. From the experimental results, the series of monomers synthesized in the present invention have a higher refractive index (the refractive index is generally higher than 1.6), while the refractive index of bisphenol A (meth) acrylate monomers currently used in the market is about 1.53. At the same time, compared with monomers with high sulfur content, the color of this series of purine compounds is lighter, and it has certain application potential in the field of high refractive optical devices. DETAILED DESCRIPTION
[0017] The present invention is described below with reference to examples, but the present invention is not limited thereto. In the art, simple replacement or improvement made by technicians in the field to the present invention belongs to the technical solution protected by the present invention.
[0018] Embodiment 1:
[0019] Taking 6-chloropurine as an example, after substitution with 4-hydroxybenzaldehyde, it is reduced under the action of a reducing agent to obtain alcohol, and then acylated with (meth)acryloyl chloride to obtain a monomer of 6-chloropurine (meth)acrylate. The reaction formula is as follows:
[0020]
[0021] Wherein, the synthesis process of compound 1-iii is as follows:
[0022] In a three-necked flask equipped with a stirring paddle and a thermometer, compound 1-ii (100 g, 0.82 mol) was dissolved in DMF (500 mL), and potassium carbonate (169.76 g, 1.23 mol) was added to the mixed solution. After stirring for 10 min, compound 1-i (133.07 g, 0.86 mol) was slowly added at room temperature. After the addition, it was stirred at room temperature for 20 min. Then, the reaction bottle was placed in an oil bath at 80 degrees and stirred for 8 hours. TLC showed that the raw material disappeared; the reaction solution was slowly quenched into 1L aqueous solution, and the product precipitated. After filtration, the filter cake was washed with water twice and dried in an oven at 60 degrees to obtain the target compound 1-iii (194.5 g, yield: 98.7%, HPLC purity: 97.6%).
[0023] The synthesis process of compound 1-iv is as follows:
[0024] In a three-necked flask equipped with a stirring paddle and a thermometer, compound 1-iii (100g, 0.416mol) was dissolved in THF (500mL), and methanol (6.66g, 0.208mol) was added to the mixed solution. The reaction solution was placed in an ice-salt bath at 0°C, and sodium borohydride (7.75g, 0.208mol) was slowly added three times, each time with an interval of 30min. After the addition, the reaction solution was stirred at the current temperature for 1h, and TLC showed that the raw material disappeared. The reaction solution was slowly quenched in 1L aqueous solution, and then 500mL of ethyl acetate was added each time, extracted three times, and the combined organic phase was washed once with saturated brine, dried over anhydrous sodium sulfate, and concentrated to remove the solvent to obtain a white solid compound 1-iv (97.5g, yield: 96.7%, HPLC purity: 98.2%)
[0025] The synthesis process of compound 1 is as follows:
[0026] In a three-necked flask equipped with a stirring paddle, a thermometer and a constant pressure dropping funnel, compound 1-iv (50g, 0.206mol) was dissolved in THF (250mL), and triethylamine (41.8g, 0.412mol) was added to the mixed solution. The reaction solution was placed in an ice-salt bath, and compound 1-v (20.51g, 0.223mol) was slowly added to the reaction solution. The temperature was kept below 5°C during the addition. After the addition, the reaction solution was slowly restored to room temperature and stirred for 5h. TLC showed that the raw material disappeared. The reaction solution was slowly quenched in 500mL of aqueous solution, and then 250mL of ethyl acetate was added each time, extracted three times, and the combined organic phase was washed once with saturated brine, dried over anhydrous sodium sulfate, purified by column chromatography, and concentrated to remove the solvent to obtain a white solid compound 1 (56g, yield: 91.76% HPLC purity: 99.1%)
[0027] The chemical structure of test compound 1 and the NMR characterization results are as follows:
[0028] 1 HNMR (400MHz, CDCl3) δ: 13.4(s,1H), 8.45(s,1H), 8.11(s,1H), 7.17(d,2H), 6.82(d,2H), 6.43(m,1H), 6.12(m,1H), 5.80(m,1H), 5.12(s,2H).
[0029] Embodiment 2:
[0030] Taking 6-chloropurine as an example, after substitution with 4-aminobenzaldehyde, it is reduced under the action of a reducing agent to obtain alcohol, and then acylated with (meth)acryloyl chloride to obtain a monomer of 6-chloropurine (meth)acrylate. The reaction formula is as follows:
[0031]
[0032] Wherein, the synthesis process of compound 2-ii is as follows:
[0033] In a three-necked flask equipped with a stirring paddle and a thermometer, compound 2-i (100 g, 0.83 mol) was dissolved in THF (500 mL), and triethylamine (167 g, 1.65 mol) was added to the mixed solution. After stirring for 10 min, 1-i (134.7 g, 0.87 mol) was slowly added at room temperature. After the addition, it was stirred at room temperature for 20 min. Then, the reaction bottle was placed in an 80-degree oil bath and stirred for 8 hours. TLC showed that the raw material disappeared; the reaction solution was slowly quenched into 1L aqueous solution, and the product precipitated. After filtration, the filter cake was washed with water twice and dried in an oven at 60 degrees to obtain the target compound 2-ii (198.5 g, yield: 98.43% HPLC purity: 95.2%).
[0034] The synthesis process of compound 2-iii is as follows:
[0035] In a three-necked flask equipped with a stirring paddle and a thermometer, compound 2-ii (100g, 0.418mol) was dissolved in THF (500mL), and methanol (6.7g, 0.209mol) was added to the mixed solution. The reaction solution was placed in an ice-salt bath at 0°C, and sodium borohydride (7.85g, 0.209mol) was slowly added three times, each time with an interval of 30min. After the addition, the reaction solution was stirred at the current temperature for 1h, and TLC showed that the raw material disappeared. The reaction solution was slowly quenched in 1L aqueous solution, and then 500mL of ethyl acetate was added each time, extracted three times, and the combined organic phase was washed once with saturated brine, dried over anhydrous sodium sulfate, and concentrated to remove the solvent to obtain a white solid compound 2-iii (95.5g, yield: 94.7% HPLC purity: 96.3%)
[0036] The synthesis process of compound 2 is as follows:
[0037] In a three-necked flask equipped with a stirring blade, a thermometer and a constant pressure dropping funnel, compound 2-iii (50g, 0.207mol) was dissolved in THF (250mL), and triethylamine (41.94g, 0.414mol) was added to the mixed solution. The reaction liquid was placed in an ice-salt bath under a nitrogen atmosphere, and compound 1-v (20.61g, 0.227mol) was slowly added to the reaction solution. The temperature was kept below 5°C during the addition. After the addition, the reaction solution was slowly restored to room temperature and stirred for 5h. TLC showed that the raw material disappeared. The reaction solution was slowly quenched in 500mL of aqueous solution, and then 250mL of ethyl acetate was added each time, extracted three times, and the combined organic phase was washed once with saturated brine, dried over anhydrous sodium sulfate, purified by column chromatography, and concentrated to remove the solvent to obtain a white solid compound 2 (58g, yield: 94.90% HPLC purity: 98.5%)
[0038] The chemical structure of test compound 2 and the NMR characterization results are as follows:
[0039] 1 HNMR (400MHz, CDCl3) δ: 13.0 (s, 1H), 8.39 (s, 1H), 8.05 (s, 1H), 6.94 (d, 2H), 6.39(d,2H),6.42(m,1H),6.11(d,1H),5.81(d,1H),5.00(s,2H),4.0(s,1H).
[0040] Embodiment 3:
[0041] (Take 4,6-dichloropurine) as an example, by substitution with methyl 4-mercaptobenzoate, then substitution with thiophenol, reduction with sodium borohydride, and then acylation to obtain the target purine compound, the reaction chemical structure of which is as follows:
[0042]
[0043] Wherein, the synthesis process of compound 9-iii is as follows:
[0044] In a three-necked flask equipped with a stirring paddle and a thermometer, compound 9-ii (100 g, 0.594 mol) was dissolved in THF (500 mL), and triethylamine (90.24 g, 0.892 mol) was added to the mixed solution. After stirring for 10 min, 9-i (112.27 g, 0.594 mol) was slowly added at room temperature. After the addition, it was stirred at room temperature for 20 min, and then the reaction solution was stirred at room temperature for 4 hours. TLC showed that the raw material disappeared; the reaction solution was slowly quenched in 1L aqueous solution, and the product precipitated. After filtration, the filter cake was washed twice with water and dried in an oven at 60 degrees to obtain the target compound 9-iii (180.5 g, yield: 95%, HPLC purity: 97.1%).
[0045] The synthesis process of compound 9-v is as follows:
[0046] In a three-necked flask equipped with a stirring paddle and a thermometer, compound 9-iv (100 g, 0.91 mol) was dissolved in DMF (300 mL), and DBU (207 g, 1.36 mol) was added to the mixed solution. After stirring for 10 min, 9-iii (320.75 g, 1.00 mol) was slowly added at room temperature. After the addition, it was stirred at 50 ° C for 20 min, and then the reaction solution was stirred at room temperature for 4 hours. TLC showed that the raw material disappeared; the reaction solution was slowly quenched in 1L saturated ammonium chloride aqueous solution, and then 500 mL of ethyl acetate was added each time, extracted three times, and the combined organic phase was washed once with saturated brine, dried over anhydrous sodium sulfate, concentrated to remove the solvent, and then column chromatography was performed to obtain a white oil 9-v (350 g, yield: 97.5% HPLC purity: 95.4%).
[0047] The synthesis process of compound 9-vi is as follows:
[0048] In a three-necked flask equipped with a stirring paddle and a thermometer, compound 9-v (100 g, 0.254 mol) and zinc chloride (0.68 g, 5 mmol) were dissolved in methanol (300 mL), and sodium borohydride (9.6 g, 0.254 mol) was slowly added three times at 0°C, with an interval of 30 min each time. After the addition, the reaction solution was stirred at the current temperature for 1 hour, and TLC showed that the raw material disappeared. The reaction solution was slowly quenched in 1L aqueous solution, and then 500 mL of ethyl acetate was added each time, extracted three times, and the combined organic phase was washed once with saturated brine, dried over anhydrous sodium sulfate, and concentrated to remove the solvent to obtain a white solid compound 9-vi (90.5 g, yield: 97.2% HPLC purity: 96.2%)
[0049] The synthesis process of compound 9 is as follows:
[0050] In a three-necked flask equipped with a stirring blade, a thermometer and a constant pressure dropping funnel, compound 9-vi (50g, 0.136mol) was dissolved in THF (250mL), and triethylamine (20.71g, 0.204mol) was added to the mixed solution. The reaction liquid was placed in an ice-salt bath under a nitrogen atmosphere, and compound 1-v (13.54g, 0.15mol) was slowly added to the reaction solution. The temperature was kept below 5°C during the addition. After the addition, the reaction solution was slowly restored to room temperature and stirred for 5h. TLC showed that the raw material disappeared. The reaction solution was slowly quenched in 500mL of aqueous solution, and then 250mL of ethyl acetate was added each time, extracted three times, and the combined organic phase was washed once with saturated brine, dried over anhydrous sodium sulfate, purified by column chromatography, concentrated to remove the solvent, and then column chromatography was performed to obtain a colorless oil compound 9 (50g, yield: 87.45.% HPLC purity: 97.5%)
[0051] The chemical structure of test compound 9 and the NMR characterization results are as follows:
[0052] 1 HNMR (400MHz, CDCl3) δ: 13.1 (s, 1H), 7.69 (s, 1H), 7.26 (d, 2H), 7.17-7.11 ( m,4H),7.05-7.0(m,3H),6.15(m,1H),6.12(m,1H),5.83(m,1H)5.12(s,2H)
[0053] The refractive index, properties and comparative data of the monomers in the present invention are as follows:
[0054]
[0055]
[0056]
[0057] Embodiment 4:
[0058] Application of compound 1 in the present invention in optical films
[0059] The above high refractive monomer containing purine structure, taking compound 1 as an example, is subjected to photoinitiated free radical polymerization. The specific operation is as follows: 2 parts by weight of photoinitiator (1173) is mixed evenly with 50 parts by weight of monomer (compound 1) and 50 parts by weight of OPPEA (diluent), and then evenly smeared on a glass slide and illuminated with a high pressure mercury lamp (lamp distance 5 cm, light intensity I 365 =1mW / cm 2 ) was irradiated to obtain an optical film of compound 1 polymerized, and the refractive index of the film was measured to be 1.60. The cured film was colorless, uniform and transparent.
[0060] Embodiment 5:
[0061] Application of compound 9 in the present invention in optical films
[0062] The above high refractive monomer containing purine structure, taking compound 9 as an example, was polymerized by photoinitiator free radical, and the specific operation was as follows: 2 parts by weight of photoinitiator (1173) was mixed with 50 parts by weight of monomer (compound 9) and 50 parts by weight of OPPEA (diluent), and then evenly spread on a glass slide, and illuminated with a high pressure mercury lamp (lamp distance 5 cm, light intensity I 365 =1mW / cm 2 ) was irradiated to obtain an optical film of compound 9 polymerized, and the refractive index of the film was measured to be 1.630. The cured film was colorless, uniform and transparent.
[0063] Embodiment 6:
[0064] Taking the compound of comparative example 1 as an example, photoinitiator free radical polymerization was carried out as follows: 2 parts by weight of photoinitiator (1173) was mixed with 50 parts by weight of monomer (comparative example 1) and 50 parts by weight of OPPEA (diluent), and then the mixture was evenly spread on a glass slide and illuminated with a high pressure mercury lamp (lamp distance 5 cm, light intensity I 365 =1mW / cm 2 ) was irradiated to obtain an optical film polymerized from the compound of Comparative Example 1, and the refractive index of the film was measured to be 1.55, and the cured film was colorless.
[0065] Embodiment 7:
[0066] Taking the compound of comparative example 2 as an example, photoinitiator free radical polymerization was carried out as follows: 2 parts by weight of photoinitiator (1173) was mixed with 50 parts by weight of monomer (comparative example 2) and 50 parts by weight of OPPEA (diluent), and then the mixture was evenly spread on a glass slide and illuminated with a high pressure mercury lamp (lamp distance 5 cm, light intensity I 365 =1mW / cm 2 ) was irradiated to obtain an optical film polymerized from the compound of Comparative Example 2, and the refractive index of the film was measured to be 1.610. The cured film was light yellow, uniform and transparent, and no bubbles were observed visually.
[0067] The above is only a preferred embodiment of the present invention. It should be pointed out that a person skilled in the art can make several modifications and improvements without departing from the inventive concept of the present invention, which all belong to the protection scope of the present invention.
Claims
1. A purine polymerizable high refractive monomer, the structural formula of which is as follows: , Where R 1 is a methyl group or a hydrogen atom, R 2 is a hydrogen atom, a methylthio group or a phenylthio group, and X is O, NH or S.
2. The monomer according to claim 1, It is characterized in that Its structural formula is as follows: , R is selected from hydrogen or methyl.
3. The monomer according to claim 1, It is characterized in that The monomers are specifically: 、 、 、 、 、 、 、 、 、 、 。 4. The monomer according to claim 1, It is characterized in that The monomers are specifically: 、 、 。 5. A purine structure-containing high-refractive monomer composition, comprising the monomer according to any one of claims 1 to 4.
6. Use of the monomer according to any one of claims 1 to 4 in an optical film.
7. Use of the composition as claimed in claim 5 in an optical film.
8. Use of the monomer according to any one of claims 1 to 4 in an optical device.
9. Use of the composition as claimed in claim 5 in optical devices.
